5038 J. Am. Chem. Soc., Vol. 123, No. 21, 2001
Lin et al.
Figure 10. Proposed mechanism for TACN/FeCl3 model reaction (X ) Cl or pyridine).
acid, 3,4-dihydroxybenzoic acid, 1,2,3-trihydroxybenzene, 48% HBr
(hydrobromic acid) were purchased from Aldrich Chemical Co. and
used as obtained without further purification. Catechol was recrystallized
from toluene. 1,4,7-Triazacyclononane (TACN) was prepared according
to the method of Erhardt et al.16 1-Oxo-4,7-diazacyclononane was
prepared according to the method of Hancock et al.17 N,N′-DiBoc-
TACN was prepared according to the method of Kovacs and Sherry.20
HPLC grade methanol and ethanol were used without further purifica-
tion, DMF was dried over anhydrous MgSO4. Fe(TACN)Cl3 was
prepared according to the method of Wieghardt.15 FeIII(TACN)-
(catechol)Cl was prepared using the method of Dei et al.9
atmosphere. Then catechol (22 mg, 0.2 mmol) was added to the
resulting suspension, followed by pyridine (15.8 mg, 0.2 mmol). The
resulting violet solution was stirred at room temperature for 4 h.
Methanol was removed under vacuum to give a purple solid. 1H NMR
(CD3OD, 300 MHz) 8.6 (2H, pyr-RH), 7.95 (1H, pyr-γH), 7.6 (2H,
pyr-âH), 6.76 (2H, cat-H), 6.68 (2H, cat-H), 2.92-3.62 (6 × 2H,
TACN-H) ppm.
Procedure A: Oxygenation of Catechol Catalyzed by FeCl2‚
4H2O. Catechol (11 mg, 0.1 mmol), FeCl2‚4H2O (20 mg, 0.1 mmol),
pyridine (24 mg, 0.3 mmol), and TACN (12.9 mg, 0.1 mmol) were
dissolved in methanol (500 mL) in a single-necked round-bottom flask.
Oxygen gas was bubbled through the reaction mixture with stirring
for 3 h, the color of the reaction solution changed from deep purple to
yellow-green over 3 h. The solvent was removed in vacuo, 10% HCl
(2 mL) was added to decompose the iron complex. The products were
extracted with diethyl ether. The organic layer was dried (Na2SO4) and
1
Physical Measurements. H and 13C NMR spectra were recorded
on a Bruker 300 spectrometer in deuterated solvents as described below.
Mass spectra were recorded on a Micromass AutoSpec mass spec-
trometer. UV/visible spectra were recorded on a Beckmann DU 7400
UV/visible spectrophotometer equipped with a temperature-control unit.
Preparation of 1,4-DiBoc-7-(3′-pyridylmethyl)-TACN (3). N,N′-
DiBoc-TACN (164.5 mg, 0.5 mmol), anhydrous K2CO3 (276 mg, 2
mmol) were suspended in 25 mL of acetonitrile. The suspension was
heated to gentle reflux (85 °C). The solution of 3-bromomethyl pyridine-
(103.2 mg, 0.6 mmol) in 5 mL of acetonitrile was added dropwise to
it. The reaction mixture was heated at reflux for 2 days. The resulting
solid was removed by filtration. The acetonitrile was removed in vacuo
and the residue dissolved in dichloromethane and purified by flash
column to give 4 as a colorless oil (94.5 mg, 45%). 1H NMR (CDCl3,
300 MHz) δH 8.38 (2H, m, pyr-H), 7.65 (1H, d, J ) 7.7, pyr-H), 7.16
(1H, m, pyr-H), 3.52 (2H, s, -pyr-CH2-N), 3.25-3.5 (4H, m, TACN),
2.9-3.2 (4H, m, TACN), 2.4-2.6 (4H, m, TACN), 1.37, 1.38 (9H, 2
x s, Boc-H), 1.30 (9H, s, Boc-H) ppm δC 194.8, 194.6, 149.9, 148.3,
136.7, 136.1, 123.1, 79.5, 79.3, 57.6, 54.0, 52.6, 52.2, 50.9, 50.3, 49.6,
28.4, 28.3 ppm; MS (FAB, m/z) 420[M]+, 364[M - CH2dCH(CH3)2]+.
Preparation of N-(3′-Pyridylmethyl)-TACN (4). 1,4-DiBoc-7-(3′-
pyridylmethyl)-TACN (50 mg, 0.24 mmol) was treated with trifluo-
roacetic acid (0.1 mL) in dichloromethane (5 mL) and stirred at room-
temperature overnight. The solvent and excess trifluoroacetic acid were
1
evaporated in vacuo. The crude product was analyzed by H NMR,
and two products were identified. 2-Hydroxymuconic semi-aldehyde
methyl ester (5), yield 50% (based on DMF as the internal standard):
1H NMR (300 MHz, CDCl3) 9.55 (d, 1H, J ) 7.8 Hz, 6-CHO), 7.51
(dd, 1H, J ) 15.3, 11.5 Hz, 4-H), 6.31 (d, 1H, J ) 11.5 Hz, 3-H),
6.21 (dd, 1H, J ) 15.3, 7.8 Hz, 5-H), 3.86 (s, 3H, 1-COOCH3) ppm;
13C NMR (75 MHz, CDCl3) 205.1, 194.1, 164.2, 144.6, 139.6, 133.3,
51.2 ppm. Muconic acid monomethyl ester (6), yield 7.5% (based on
DMF as the internal standard): δH (300 MHz, CDCl3) 7.93 (dd, 0.15H,
J ) 10.8, 10.8 Hz, 3-H), 7.80 (dd, 0.15H, J ) 10.8, 10.8 Hz, 4-H), 6.0
(m, 0.3H, 2-H and 5-H), 3.7 (s, 0.45H, 1-COOCH3) ppm. MS(CI, m/z)
188[M + NH4]+, 171[M + H]+, 128[M - 43]+.
Oxygenation of Catechol Catalyzed by FeCl3‚6H2O. As procedure
A, except FeCl2‚4H2O was replaced by FeCl3‚6H2O, and the reaction
time extended to 5 h. NMR spectrum of crude product showed the
formation of extradiol RFP and intradiol RFP, in a ratio of 2:1
Oxygenation of Catechol Catalyzed by TACN/FeCl2 in Ethanol.
As procedure A, except methanol was replaced by ethanol. The product
2-hydroxy-6-oxo-hexa-2,4-dienoic acid ethyl ester was identified by
1
1
removed in vacuo, to give 4. H NMR (D2O, 300 MHz) 7.92 (s, 1H,
NMR analysis as the major product. H NMR (CDCl3, 300 MHz) δH
2′-H), 7.91 (d, 1H, J ) 6.0 Hz, 6′-H), 7.59 (d, 1H, J ) 7.5 Hz, 4′-H),
7.45 (dd, 1H, J ) 7.5, 6.0 Hz, 5′-H), 3.85 (s, 2H,), 3.53 (s, 4H), 3.12
(dd, 4H, J ) 6.0, 5.1 Hz), 2.91 (dd, 4H, J ) 6.0, 5.1 Hz) ppm; MS
(FAB, m/z) 221[M + H]+.
9.56 (d, 1H, J ) 8.1 Hz, -CHO), 7.52 (dd, 1H, J ) 15.6, 11.6 Hz,
4-H), 6.31 (d, 1H, J ) 11.6 Hz, 3-H), 6.2 (dd, 1H, J ) 15.6, 8.1 Hz,
5-H), 4.31 (q, 2H, J ) 7.2 Hz, -OCH2-), 1.32 (t, 3H, J ) 7.2 Hz,
-CH3) ppm. MS (CI, m/z) 188[M + NH4]+, 171[M + H]+, 153[M +
H-CO]+.
Preparation of FeII(TACN)(Catechol) Complex. A modification
of the method of Dei et al. was used.9 A solution of TACN (25.8 mg,
0.2 mmol) in 1 mL of degassed methanol was added to a degassed
solution of FeCl2‚4H2O (39.6 mg, 0.2 mmol) in 3 mL of methanol.
The solution was gently warmed to 40 °C for 0.5 h under N2
Oxygenation of Substituted Catechols Using TACN/FeCl2 in
Methanol. As procedure A, except catechol was replaced by a
substituted catechol. In each case, the products and product ratios were
1
determined by H NMR spectroscopy.